Hospitalization

Among outpatients with respiratory syncytial virus, one in 20 experienced all-cause hospitalization, according to a recent study.

BOSTON — Among adults with COPD, the odds for exacerbations and hospitalizations were elevated in patients who did not use vs. did use the diabetes medication metformin, according to an abstract presented at the CHEST Annual Meeting.

Respiratory syncytial virus vaccines proved highly effective at preventing hospitalization and ED visits in older adults, even in those with immunocompromising conditions, results from an observational analysis showed.

BOSTON — Fewer patients with moderate to severe COPD used health care resources related to the disease if they received ensifentrine for 48 weeks, according to a presentation at the CHEST Annual Meeting.

SAN DIEGO — Researchers reported a sudden decrease in all-cause hospitalization at the beginning of the COVID-19 pandemic, but there was an increase in all-cause mortality in patients on maintenance dialysis.

As older Americans continue to shoulder much of the COVID-19 burden, new data show that most went without a vaccine last winter and that those who got sick rarely received antivirals.

BOSTON — Having a COPD exacerbation hospitalization in combination with COVID-19 vs. no COVID-19 significantly raised the odds for mortality and invasive ventilation, according to a poster presented at the CHEST Annual Meeting.

BOSTON — Patients hospitalized with both asthma exacerbations and COVID-19 had worse outcomes than those hospitalized for either of those conditions alone, according to a poster presented at the CHEST Annual Meeting.

A combination of remdesivir plus dexamethasone significantly reduced the risk for death among people hospitalized with COVID-19 with baseline oxygen requirements compared with dexamethasone alone, according to a study.